LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 1 | 30.64 | 17.25 | 251 | 1887 | 0.1330 | 0.4848 | MN20160310_N02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 30.64 | 17.25 | 1277 | 1887 | 0.6766 | 0.8879 | MN20160310_N02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 30.64 | 17.25 | 408 | 1887 | 0.2162 | 0.5952 | MN20160310_N02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 30.64 | 17.25 | 1338 | 1887 | 0.7089 | 0.9010 | MN20160310_N02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 32.61 | 17.25 | 279 | 2136 | 0.1306 | 0.4923 | MN20160310_N02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 32.61 | 17.25 | 1262 | 2136 | 0.5907 | 0.8542 | MN20160310_N02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 32.61 | 17.25 | 514 | 2136 | 0.2406 | 0.6294 | MN20160310_N02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 32.61 | 17.25 | 1336 | 2136 | 0.6254 | 0.8694 | MN20160310_N02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 34.57 | 17.25 | 524 | 2523 | 0.2077 | 0.6074 | MN20160310_N02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 34.57 | 17.25 | 1261 | 2523 | 0.4998 | 0.8161 | MN20160310_N02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 34.57 | 17.25 | 931 | 2523 | 0.3690 | 0.7411 | MN20160310_N02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 34.57 | 17.25 | 1348 | 2523 | 0.5343 | 0.8331 | MN20160310_N02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 36.54 | 17.25 | 602 | 2679 | 0.2246 | 0.6291 | MN20160310_N02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 36.54 | 17.25 | 1278 | 2679 | 0.4769 | 0.8066 | MN20160310_N02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 36.54 | 17.25 | 977 | 2679 | 0.3646 | 0.7411 | MN20160310_N02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 36.54 | 17.25 | 1344 | 2679 | 0.5015 | 0.8191 | MN20160310_N02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 38.51 | 17.25 | 623 | 2906 | 0.2144 | 0.6241 | MN20160310_N02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 38.51 | 17.25 | 1263 | 2906 | 0.4346 | 0.7869 | MN20160310_N02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 38.51 | 17.25 | 1014 | 2906 | 0.3489 | 0.7346 | MN20160310_N02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 38.51 | 17.25 | 1350 | 2906 | 0.4645 | 0.8031 | MN20160310_N02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 40.48 | 17.25 | 652 | 3125 | 0.2086 | 0.6229 | MN20160310_N02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 40.48 | 17.25 | 1265 | 3125 | 0.4047 | 0.7728 | MN20160310_N02 | I09 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 40.48 | 17.25 | 1032 | 3125 | 0.3302 | 0.7253 | MN20160310_N02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 40.48 | 17.25 | 1343 | 3125 | 0.4297 | 0.7870 | MN20160310_N02 | I10 |
| MCF 10A-H2B-mCherry | Trametinib | 1 | 42.45 | 17.25 | 647 | 3504 | 0.1846 | 0.6045 | MN20160310_N02 | I09 |